Management of tics and Tourette's disorder: an update

Bibliography

• Diagnostic and statistical manual of mental disorders IV text revision, American Psychiatric Association; 2000
   Google Scholar
• Robertson MM, Eapen V, Cavanna AE. The international prevalence, epidemiology and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res 2009;67(6):475-83
   PubMedGoogle Scholar
• Khalifa N, von Knorring AL. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 2003;45:315-19
   PubMed Web of Science ®Google Scholar
• Khalifa N, von Knorring AL. Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry 2006;45:1346-53
   PubMed Web of Science ®Google Scholar
• Bloch MH, Peterson BS, Scahill L, Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160:65-19
   PubMedGoogle Scholar
• Sukhodolsky DG, Scahill L, Zhang H, Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 2003;42:98-105
   PubMed Web of Science ®Google Scholar
• Leckman JF, Grice DE, Barr LC, Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1994;1:208-15
   PubMedGoogle Scholar
• Gaze C, Kepley HO, Walkup JT. Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome. J Child Neurol 2006;21(8):, 657-64
   PubMedGoogle Scholar
• Leckman JF, Zhang H, Vitale A, Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998;102(1 Pt 1):14-9
   PubMedGoogle Scholar
• Lin H, Katsovitch L, Ghebremichael M, Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 2007;48(2):157-66
   PubMedGoogle Scholar
• Woods DW, Watson TS, Wolfe E, Analyzing the influence of tic related talk on vocal and motor tics in children with Tourette's syndrome. J Appl Behav Anal 2001;34(3):353-6
   PubMedGoogle Scholar
• Silvestri R, De Domenico P, Di Rosa AE, The effect of nocturnal physiological sleep on various movement disorders. Mov Disord 1990;5(1):8-14
   PubMedGoogle Scholar
• Keen-Kim D, Freimer NB. Genetics and epidemiology of Tourette's syndrome. J Child Neurol 2006;21:665-71
   PubMed Web of Science ®Google Scholar
• Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993;150:98-102
   PubMed Web of Science ®Google Scholar
• Woods DW, Piacentini J, Himle MB, Chang S. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with Tic disorders. J Dev Behav Pediatr 2005;26:397-403
   PubMed Web of Science ®Google Scholar
• Peterson BS, Leckman JF. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 1998;44:1337-48
   PubMed Web of Science ®Google Scholar
• Singer HS. Tourette's syndrome: from behaviour to biology. Lancet Neurol 2005;4:149-59
   PubMed Web of Science ®Google Scholar
• Harris K, Singer HS. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurol 2006;21(8):678-89
   PubMedGoogle Scholar
• Pulst SM, Walshe TM, Romero JA. Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. Arch Neurol 1983;40:443-4
   PubMedGoogle Scholar
• Kwak CH, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord 2002;17:821-5
   PubMed Web of Science ®Google Scholar
• Pascual-Leone A, Dhuna A. Cocaine-associated multifocal tics. Neurology 1990;40:999-1000
   PubMedGoogle Scholar
• Sotero de Menezes MA, Rho JM, Murphy P, Cheyette S. Lamotrigine-induced tic disorder: report of five pediatric cases. Epilepsia 2000;41:862-7
   PubMedGoogle Scholar
• Kurlan R, Kersun J, Behr J, Carbamazepine-induced tics. Clin Neuropharmacol 1989;12:298-302
   PubMed Web of Science ®Google Scholar
• Bharucha KJ, Sethi KD. Tardive tourettism after exposure to neuroleptic therapy. Mov Disord 1995;10:791-3
   PubMed Web of Science ®Google Scholar
• Polizos P, Engelhardt DM, Hoffman SP, Waizer J. Neurological consequences of psychotropic drug withdrawal in schizophrenic children. J Autism Child Schizophr 1973;3:247-53
   PubMedGoogle Scholar
• Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord 2007;22(12):1743-50
   PubMedGoogle Scholar
• Martino D, Defazio G, Giovannoni G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res 2009;67(6):547-57
   PubMedGoogle Scholar
• Albin RL, Koeppe RA, Bohnen NI, Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003;61(3):310-5
   PubMedGoogle Scholar
• Sallee FR, Nesbitt L, Jackson C, Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997;154:1057-62
   PubMed Web of Science ®Google Scholar
• Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 1978;135:585-7
   PubMed Web of Science ®Google Scholar
• Goetz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders. Arch Neurol 1984;41:271-2
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Marras C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 2009;(2): CD006996
   PubMedGoogle Scholar
• Jensen PS, Buitelaar J, Pandina GJ, Management of psychiatric disorders in children and adolescents with atypical antipsychotics A systematic review of published clinical trials. Eur Child Adolesc Psychiatry 2007;16:104-120
   PubMed Web of Science ®Google Scholar
• Sallee FR, Kurlan R, Goetz CG, Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000;39:292-9
   PubMed Web of Science ®Google Scholar
• Yoo HK, Choi SH, Park S, An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. J Clin Psychiatry 2007;68:1088-93
   PubMed Web of Science ®Google Scholar
• Lyon GJ, Samar S, Jummani R, Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. J child Adolesc Psychopharmacol 2009;19(6):623-33
   PubMedGoogle Scholar
• Murphy TK, Mutch PJ, Reid JM, Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol 2009;19(4):441-7
   PubMedGoogle Scholar
• Budman C, Coffey BJ, Shechter R, Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol 2008;18(5):509-15
   PubMedGoogle Scholar
• Onofrj M, Paci C, D'Andreamatteo G, Toma L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 2000;247:443-6
   PubMed Web of Science ®Google Scholar
• Ho CS, Chen HJ, Chiu NC, Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc 2009;108(10):788-93
   PubMedGoogle Scholar
• Fountoulakis KN, Iacovides A, St Kaprinis G. Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 2004;38(5):901
   PubMedGoogle Scholar
• Tourette Syndrome Study Group. Treatment of ADHD in children with tics: A randomized controlled trial. Neurology 2002;58:527-36
   PubMed Web of Science ®Google Scholar
• Scahill L, Chappell PB, Kim YS, A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1067-74
   PubMed Web of Science ®Google Scholar
• King A, Harris P, Fritzell J, Kurlan R. Syncope in children with Tourette's syndrome treated with guanfacine. Mov Disord 2006;21:419-20
   PubMed Web of Science ®Google Scholar
• Black KJ, Mink JW. Response to levodopa challenge in Tourette syndrome. Mov Disord 2000;15:1194-8
   PubMed Web of Science ®Google Scholar
• Anca MH, Giladi N, Korczyn AD. Ropinirole in Gilles de la Tourette syndrome. Neurology 2004;62:1626-7
   PubMedGoogle Scholar
• Pramipexole Pilot Phase II Study in children and adolescents with tourette disorder according to DSM-IV criteria. Available from: http://clinicaltrials.gov/ct2/show/NCT00558467?term= pramipexole+tourette&rank=1 [Last accessed 25 Feb 2010]
   Google Scholar
• Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009;8(9):844-56
   PubMedGoogle Scholar
• Hoekstra PJ, Anderson GM, Limburg PC, Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 2004;61(7-8):886-98
   PubMedGoogle Scholar
• Singer HS, Minzer K. Neurobiology of Tourette syndrome: concepts of neuroanatomical localization and neurochemical abnormalities. Brain Dev 2003;25(Suppl):S70-84
   Google Scholar
• Steingard RJ, Goldberg M, Lee D, DeMaso DR. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. J Am Acad Child Adolesc Psychiatry 1994;33:394-9
   PubMedGoogle Scholar
• Troung DD, Bressman S, Shale H, Fahn S. Clonazepam, haloperidol, and clonidine in tic disorders. South Med J 1988;81:1103-5
   PubMed Web of Science ®Google Scholar
• Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a doubleblind, placebo-controlled, crossover trial. Neurology 2001;56:599-604
   PubMed Web of Science ®Google Scholar
• Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and Levetiracetam in Tourette syndrome. Pediatr Neurol 2009;40(6):420-5
   PubMedGoogle Scholar
• Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Move Disord 2007;22:1764-70
   PubMed Web of Science ®Google Scholar
• Awaad Y, Michon AM, Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Move Disord 2005;20:714-8
   PubMed Web of Science ®Google Scholar
• Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010;81(1):70-3
   PubMedGoogle Scholar
• Cubo E, Fernández Jaén A, Moreno C, Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Clin Ther 2008;30(1):182-9
   PubMedGoogle Scholar
• Grant P, Lougee L, Hirschtritt M, Swedo SE. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive–compulsive disorder. J Child Adolesc Psychopharmacol 2007;17(6):761-7
   PubMed Web of Science ®Google Scholar
• Feusner JD, Kerwin L, Saxena S, Bystritsky A. Differential Efficacy of memantine for obsessive–compulsive disorder vs. generalized anxiety disorder: an open-label trial. Psychopharmacol Bull 2009;42(1):81-93
   PubMedGoogle Scholar
• Wilhelm S, Buhlmann U, Tolin DF, Augmentation of behavior therapy with D-cycloserine for obsessive–compulsive disorder. Am J Psychiatry 2008;165(3):335-41, quiz 409
   PubMedGoogle Scholar
• Haugbol S, Pinborg LH, Regeur L, Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 2007;10:245-52
   PubMed Web of Science ®Google Scholar
• Bonnier C, Nassogne MC, Evrard P. Ketanserin treatment of Tourette's syndrome in children. Am J Psychiatry 1999;156:1122-3
   PubMed Web of Science ®Google Scholar
• Toren P, Laor N, Cohen DJ, Ondansetron treatment in patients with Tourette's syndrome. Int Clin Psychopharmacol 1999;14(6):373-6
   PubMedGoogle Scholar
• Toren P, Weizman A, Ratner S, Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2005;66:499-503
   PubMed Web of Science ®Google Scholar
• Marinelli M, Rudick CN, Hu XT, White FJ. Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets 2006;5:79-97
   PubMedGoogle Scholar
• Peterson BS, Leckman JF, Scahill L, steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992;17(6):553-63
   PubMedGoogle Scholar
• Peterson BS, Zhang H, Anderson GM, Leckman JF. Double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. J Clin Psychopharmacol 1998;18(4):324-31
   PubMedGoogle Scholar
• Bortolato M, Muroni A, Marrosu F. Treatment of Tourette's syndrome with finasteride. Am J Psychiatry 2007;164:1914-15
   PubMedGoogle Scholar
• Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol 2003;2:291-8
   PubMed Web of Science ®Google Scholar
• Romero J, Lastres-Becker I, de Miguel R, The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects. Pharmacol Ther 2002;95:137-52
   PubMedGoogle Scholar
• Curtis A, Clarke CE, Rickards HE. Cannabinoids for Tourette's Syndrome. Cochrane Database Syst Rev 2009;(4): CD006565
   Google Scholar
• Marras C, Andrews D, Sime EA, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001;56:605-10
   PubMed Web of Science ®Google Scholar
• Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord 2008;14:443-45
   PubMedGoogle Scholar
• Bloch MH. Emerging treatments for Tourette's disorder. Curr Psychiatry Rep 2008;10(4):323-30
   PubMedGoogle Scholar
• Orth M. Transcranial magnetic stimulation in Gilles de la Tourette syndrome. J Psychosom Res 2009;67(6):591-98
   PubMedGoogle Scholar
• Transcranial Magnetic Stimulation (TMS) for Individuals With Severe Tourette's Syndrome. Available from: http://clinicaltrials.gov/ct2/show/NCT00529308?term=tics+rTMS&rank=3 on 25 Feb 2010
   Google Scholar
• Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome (rTMSPPCGT). Available from: http://clinicaltrials.gov/ct2/show/NCT01043549?term=tics+rTMS&rank=1 on 25 Feb 2010
   Google Scholar
• Porta M, Servello D, Sassi M, Issues related to deep brain stimulation for treatment-refractory Tourette's syndrome. Eur Neurol 2009;62(5):264-73
   PubMedGoogle Scholar
• Thalamic Deep Brain Stimulation for Tourette Syndrome. Available from: http://clinicaltrials.gov/ct2/show/NCT00311909?term=dbs+tics&rank=1 on 27 Feb 2010
   Google Scholar
• Pallidal Stimulation and Gilles de la Tourette Syndrome (STIC). Available from: http://clinicaltrials.gov/ct2/show/NCT00478842?term=dbs+tics&rank=2 on 27 Feb 2010
   Google Scholar
• Piacentini J, Chang S. Habit reversal training for tic disorders in children and adolescents. Behav Modif 2005;29(6):803-22
   PubMedGoogle Scholar
• Wetterneck C, Woods D. An evaluation of the effectiveness of exposure and response prevention on repetitive behaviours associated with Tourette's syndrome. J Appl Behav Anal 2006;39(4):441-4
   PubMedGoogle Scholar
• Deckersbach T, Rauch S, Buhlmann U, Wilhelm S. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 2006;44(8):1079-90
   PubMedGoogle Scholar
• Goodman WK, Storch EA, Geffken GR, Murphy TK. Obsessive-compulsive disorder in Tourette syndrome 2006;21(8):704-14
   Google Scholar
• Bloch MH, Landeros-Weisenberger A, Kelmendi B, A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006;11:622-32
   PubMed Web of Science ®Google Scholar